
Micah Paul Young
Examiner (ID: 7687, Phone: (571)272-0608 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1615, 1618 |
| Total Applications | 1410 |
| Issued Applications | 631 |
| Pending Applications | 181 |
| Abandoned Applications | 616 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18691080
[patent_doc_number] => 20230321287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => RADIOLABELLED GRPR-ANTAGONIST FOR USE AS THERAGNOSTIC
[patent_app_type] => utility
[patent_app_number] => 17/754059
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17754059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/754059 | RADIOLABELLED GRPR-ANTAGONIST FOR USE AS THERAGNOSTIC | Sep 22, 2020 | Pending |
Array
(
[id] => 17988803
[patent_doc_number] => 20220354840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => NICOTINE POUCH
[patent_app_type] => utility
[patent_app_number] => 17/761918
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/761918 | NICOTINE POUCH | Sep 16, 2020 | Pending |
Array
(
[id] => 18019143
[patent_doc_number] => 20220370642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHODS OF DETECTING NEUROLOGICAL DISORDERS VIA BINDING TO PHOSPHORYLATED TAU PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/760854
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760854 | METHODS OF DETECTING NEUROLOGICAL DISORDERS VIA BINDING TO PHOSPHORYLATED TAU PROTEIN | Sep 16, 2020 | Pending |
Array
(
[id] => 16554991
[patent_doc_number] => 20210000139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => ANIMAL FEED ADDITIVE AND ANIMAL FEED
[patent_app_type] => utility
[patent_app_number] => 17/021085
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7068
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021085
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021085 | ANIMAL FEED ADDITIVE AND ANIMAL FEED | Sep 14, 2020 | Pending |
Array
(
[id] => 16648681
[patent_doc_number] => 10925835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Celecoxib and amlodipine formulation and method of making the same
[patent_app_type] => utility
[patent_app_number] => 17/006959
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7278
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17006959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/006959 | Celecoxib and amlodipine formulation and method of making the same | Aug 30, 2020 | Issued |
Array
(
[id] => 17864923
[patent_doc_number] => 20220287658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12
[patent_app_type] => utility
[patent_app_number] => 17/636107
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17636107
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/636107 | IN VIVO IMMUNOIMAGING OF INTERLEUKIN-12 | Aug 18, 2020 | Pending |
Array
(
[id] => 17789579
[patent_doc_number] => 20220248670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => FABRIC SPRAY COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/630021
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630021 | FABRIC SPRAY COMPOSITIONS | Jul 23, 2020 | Abandoned |
Array
(
[id] => 16420445
[patent_doc_number] => 20200345643
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => TWIN-SCREW DRY GRANULATION FOR PRODUCING SOLID FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/936008
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936008
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936008 | Twin-screw dry granulation for producing solid formulations | Jul 21, 2020 | Issued |
Array
(
[id] => 17805778
[patent_doc_number] => 20220257613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => DISPERSIBLE TABLETS OF ABIRATERONE ACETATE
[patent_app_type] => utility
[patent_app_number] => 17/624842
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624842 | Dispersible tablets of abiraterone acetate | Jul 1, 2020 | Issued |
Array
(
[id] => 19716076
[patent_doc_number] => 12201591
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-21
[patent_title] => Sustained release compositions of endoxifen
[patent_app_type] => utility
[patent_app_number] => 17/624329
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 61835
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624329 | Sustained release compositions of endoxifen | Jul 1, 2020 | Issued |
Array
(
[id] => 16710270
[patent_doc_number] => 20210077417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => Methods and Compositions Particularly for Treatment of Attention Deficit Disorder
[patent_app_type] => utility
[patent_app_number] => 16/899962
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899962 | Methods and Compositions Particularly for Treatment of Attention Deficit Disorder | Jun 11, 2020 | Abandoned |
Array
(
[id] => 16841628
[patent_doc_number] => 11013687
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-05-25
[patent_title] => Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2
[patent_app_type] => utility
[patent_app_number] => 16/900488
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13297
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900488 | Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2 | Jun 11, 2020 | Issued |
Array
(
[id] => 16482487
[patent_doc_number] => 20200376087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING OR REDUCING HYPOXIA-ISCHEMIA INDUCED BRAIN DAMAGE AND NEUROBEHAVIORAL DYSFUNCTION IN NEONATES
[patent_app_type] => utility
[patent_app_number] => 16/891789
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891789
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/891789 | Compositions, systems, and methods for treating or reducing hypoxia-ischemia induced brain damage and neurobehavioral dysfunction in neonates | Jun 2, 2020 | Issued |
Array
(
[id] => 19930407
[patent_doc_number] => 12303600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Magnetic assisted drug delivery
[patent_app_type] => utility
[patent_app_number] => 16/888355
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 0
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888355 | Magnetic assisted drug delivery | May 28, 2020 | Issued |
Array
(
[id] => 17790283
[patent_doc_number] => 20220249374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => RADIOTHERAPEUTIC MICROSPHERES
[patent_app_type] => utility
[patent_app_number] => 17/611929
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611929 | RADIOTHERAPEUTIC MICROSPHERES | May 20, 2020 | Pending |
Array
(
[id] => 16251998
[patent_doc_number] => 20200261372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => EXTENDED RELEASE COMPOSITIONS COMPRISING TRIHEXYPHENIDYL
[patent_app_type] => utility
[patent_app_number] => 16/864638
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864638 | Extended release compositions comprising trihexyphenidyl | Apr 30, 2020 | Issued |
Array
(
[id] => 16389262
[patent_doc_number] => 20200330203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => HEMOSTATIC PASTE WITH LIGHT-CURABLE FEATURE
[patent_app_type] => utility
[patent_app_number] => 16/850602
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850602
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850602 | HEMOSTATIC PASTE WITH LIGHT-CURABLE FEATURE | Apr 15, 2020 | Pending |
Array
(
[id] => 16359503
[patent_doc_number] => 20200316254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => THREE-DIMENSIONAL BIOPRINTING OF CARDIAC PATCH WITH ANISOTROPIC AND PERFUSABLE ARCHITECTURE
[patent_app_type] => utility
[patent_app_number] => 16/845329
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845329
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/845329 | Three-dimensional bioprinting of cardiac patch with anisotropic and perfusable architecture | Apr 9, 2020 | Issued |
Array
(
[id] => 17655335
[patent_doc_number] => 20220175800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => DISPERSIBLE TABLET COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/602934
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602934 | DISPERSIBLE TABLET COMPOSITION | Apr 9, 2020 | Abandoned |
Array
(
[id] => 17444356
[patent_doc_number] => 20220064861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => GERM-REPELLENT BOOK AND FOOD PAPER PACKAGING, AND METHOD OF MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 17/310125
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310125 | Germ-repellent book and food paper packaging, and method of manufacture | Apr 6, 2020 | Issued |